@fangusaro

Pediatric Neuro-Oncologist and Developmental Therapeutics Clinical Researcher

 Atlanta, GA
winshipcancer.emory.edu/bios/faculty/fangusaro-jason.html
Joined April 2021
  • Tweets2
  • Following2
  • Followers44
Jason Fangusaro retweeted
PBTC Foundation@PbtcF22 Apr 2021
Great research at work! pubmed.ncbi.nlm.nih.gov/3363… "Over 70% of children with recurrent optic pathway/hypothalamic low-grade glioma had shrinkage or stability of their tumor using selumetinib (an oral agent)."

A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade...

Selumetinib was tolerable and led to responses and prolonged disease stability in children with recurrent/progressive OPHGs based upon radiographic response, PFS, and visual outcomes.

pubmed.ncbi.nlm.nih.gov
1
2
Load more